Home
Symposium Overview
+
2022 SABCS
®
2022 Symposium Overview
Call for Abstracts 2022
2022 Preliminary Program
+
SABCS
®
Hotels
Shuttle Bus
Hotel Warning Alert
International Reservations
+
SABCS
®
Registration
Group Registration
Patient Advocates
Support & Exhibits
Satellite Symposia
Media
+
Travel & Transportation
Information for International Travelers
FAQs
Best Of SABCS
®
+
Resource Library
Past Meetings Press Releases
Contact
Gallery
Media
|
Gallery
|
Contact
Home
Symposium Overview
2022 SABCS
®
2022 Symposium Overview
Call for Abstracts 2022
2022 Preliminary Program
SABCS
®
Hotels
Shuttle Bus
Hotel Warning Alert
International Reservations
SABCS
®
Registration
Group Registration
Patient Advocates
Support & Exhibits
Satellite Symposia
Media
Travel & Transportation
Information for International Travelers
FAQs
Best Of SABCS
®
Resource Library
Past Meetings Press Releases
Contact
Gallery
Home
/
2021 SABCS
®
/
2021 SABCS Program
/
Spotlight Sessions
/
Special Poster Discussion 2
2021 SABCS Updated Program Book
Schedule at a Glance
Daily Schedule:
Day 1: Tuesday, 12/7/2021
Day 2: Wednesday, 12/8/2021
Day 3: Thursday, 12/9/2021
Day 4: Friday, 12/10/2021
Poster Sessions:
Poster Session 1
Poster Session 2
Poster Session 3
Poster Session 4
Poster Session 5
Ongoing Trials Poster Session 1
Ongoing Trials Poster Session 2
Spotlight Sessions:
PD1 Endocrine Resistance: Novel mechanisms and emerging new therapies
PD2 Insights to CDK4/6i resistance: Novel models and clinical/translational genomics
PD3 Targets in Triple Negative Breast Cancer
PD4 Brain Metastases: Managing LMD / Targeting HER2
PD5 Life after breast cancer: Cardiac health, fertility preservation, and returning to life
PD6 Genomic and genetic analysis on metastases
PD7 Locoregional treatment: De-escalation in breast cancer
PD8 Novel therapies for HER2+ disease
PD9 Evaluating emerging and established biomarkers
PD10 Novel immunotherapy approaches
PD11 The future is now: Innovation in pathology and radiology
PD13 Novel therapeutics
PD14 Clinical translational updates in invasive lobular carcinoma
PD15 Defining molecular markers of endocrine resistance in clinic
Your browser does not support inline frames
In collaboration with
and